Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Enanta Pharma (ENTA) Receives $30M Milestone from AbbVie
November 20, 2015 9:06 AM ESTEnanta Pharma (NASDAQ: ENTA) disclosed the following on Friday morning:
Enanta Pharmaceuticals, Inc. has earned a $30 million milestone payment from AbbVie following the recent price reimbursement approval in Japan of AbbVies VIEKIRAX treatment for HCV infection, which had been approved for regulatory... More
New Treasury Guidelines on Inversion May Not Apply to Allergan (AGN)/Pfizer (PFE) - Evercore ISI's Raffat
November 20, 2015 8:33 AM ESTThere's lots of analyst chatter this morning on the pending Allergan (NYSE: AGN), Pfizer (NYSE: PFE) deal amid the... More
